Cerebellopontine angle embryonal tumor

disease
On this page

Also known as C-P angle PNETC-P angle primitive neuroectodermal neoplasmC-P angle primitive neuroectodermal tumorC-P angle primitive neuroectodermal tumourcerebellar Pontine angle PNETcerebellar Pontine angle primitive neuroectodermal neoplasmcerebellar Pontine angle primitive neuroectodermal tumorcerebellar Pontine angle primitive neuroectodermal tumourcerebellopontine angle PNETcerebellopontine angle primitive neuroectodermal neoplasmcerebellopontine angle primitive neuroectodermal tumorcerebellopontine angle primitive neuroectodermal tumourprimitive neuroectodermal neoplasm of C-P angleprimitive neuroectodermal neoplasm of cerebellar Pontine angleprimitive neuroectodermal neoplasm of cerebellopontine angleprimitive neuroectodermal neoplasm of the C-P angleprimitive neuroectodermal neoplasm of the cerebellar Pontine angleprimitive neuroectodermal neoplasm of the cerebellopontine angleprimitive neuroectodermal tumor of C-P angleprimitive neuroectodermal tumor of cerebellar Pontine angle

Summary

Cerebellopontine angle embryonal tumor (MONDO:0003141) is a cancer. A subtype of cerebellopontine angle tumor — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namecerebellopontine angle embryonal tumor
Mondo IDMONDO:0003141
DOIDDOID:4787
NCITC5436
UMLSC1332904
MedGen232045
GARD0027630
Is cancer (heuristic)yes

Also known as: C-P angle PNET · C-P angle primitive neuroectodermal neoplasm · C-P angle primitive neuroectodermal tumor · C-P angle primitive neuroectodermal tumour · cerebellar Pontine angle PNET · cerebellar Pontine angle primitive neuroectodermal neoplasm · cerebellar Pontine angle primitive neuroectodermal tumor · cerebellar Pontine angle primitive neuroectodermal tumour · cerebellopontine angle PNET · cerebellopontine angle primitive neuroectodermal neoplasm · cerebellopontine angle primitive neuroectodermal tumor · cerebellopontine angle primitive neuroectodermal tumour · primitive neuroectodermal neoplasm of C-P angle · primitive neuroectodermal neoplasm of cerebellar Pontine angle · primitive neuroectodermal neoplasm of cerebellopontine angle · primitive neuroectodermal neoplasm of the C-P angle · primitive neuroectodermal neoplasm of the cerebellar Pontine angle · primitive neuroectodermal neoplasm of the cerebellopontine angle · primitive neuroectodermal tumor of C-P angle · primitive neuroectodermal tumor of cerebellar Pontine angle (+10 more)

Disease family

Classification path: disease › human disease › disease by body system or component › nervous system disordercentral nervous system disorderbrain disorderbrain neoplasm › cerebellopontine angle tumor › cerebellopontine angle embryonal tumor

Related subtypes (2): c-P angle neurinoma, cerebellopontine angle meningioma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.